Coherus Biosciences | Costo Del Venduto



Cost Of Sales Cambiamento Data
AbbVie USD 4B 394M 2025-03
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
ALKERMES USD 49.2M 12.92M 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amarin USD 16.89M 18.51M 2025-03
Amgen USD 2.6B 507M 2025-03
Baxter International USD 1.74B 73M 2024-12
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Fujifilm JPY 523.98B 45.33B 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Merck USD 2.76B 944M 2025-03
Myriad Genetics USD 61.7M 2M 2025-03
Pacira USD 34.31M 5.58M 2025-03
Perrigo USD 651.6M 100.8M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
PTC Therapeutics USD 12.86M 3.42M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Teva Pharmaceutical Industries USD 1.98B 132M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Xencor 10.71M 4.56M 2024-09
Zoetis USD 622M 85M 2025-03



Coherus Biosciences Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.